Donald Trump's tariff tussle: Duties on Indian pharma would be...

Dununu.com Dununu

Gesponsert

Donald Trump's tariff tussle: Duties on Indian pharma would be 'counterproductive’; America may take at least 3 years to match India’s scale, says Pharmexcil

RSS Feed Business

Posted

42

Despite increased tariffs on Indian imports, the US has temporarily exempted the pharmaceutical sector, recognizing India's critical role in supplying affordable medicines. Pharmexcil emphasizes that tariffs on Indian pharma would harm American consumers, as Indian companies produce low-cost generics. India supplies over 40% of US generic medicines, maintaining high quality standards with numerous FDA-approved facilities.

Read Full Article

Please log in to like, share and comment!

Nestle India’s maiden 1:1 bonus issue today: FMCG firm eyes enhanced stock liquidity, improved affordability for retail investors— What shareholders should know

Nestle India has set August 8 as the record date for its first-ever 1:1 bonus share issue, a move...

Von 0 2

Oman Air, in partnership with TUI launches 'Oman Air Holidays' offering travel packages in 20+ destinations

Oman Air, in collaboration with TUI, has launched 'Oman Air Holidays,' a digital platform...

Von 0 12

ICE lifts age cap: Agency to hire 10,000 new applicants; local sheriffs alarmed

US Immigration and Customs Enforcement has eliminated its age limit for deportation agent...

Von 0 12

Saudi Premium Residency update: Over 40,000 applications filed between Jan 2024–Jul 2025

Saudi Arabia's Premium Residency program sees great interest. Over 40,000 applications came in...

Von 0 12

'Debanking': Donald Trump orders federal regulators to probe alleged bank bias; seeks to eliminate 'reputational risk' in regulations

Von 0 13